Income Statement - Tarsus Pharmaceuticals, Inc. (TARS)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 451.36 | 182.95 | 17.45 | 25.82 | 57.03 | 33.43 | 0.00 | 0.00 |
| Cost of revenue | 30.68 | 12.83 | 1.59 | 0.96 | 2.08 | 0.25 | 0.07 | 0.00 |
| Gross profit | 420.68 | 170.13 | 15.85 | 24.86 | 54.95 | -0.25 | -0.07 | 0.00 |
| Total operating expenses | 491.65 | 290.70 | 159.01 | 87.57 | 67.11 | 26.74 | 4.22 | 1.35 |
| Operating income | -70.97 | -120.57 | -143.16 | -62.71 | -12.16 | -26.98 | -4.30 | -1.35 |
| Non-operating income (net) | 6.61 | 5.02 | 7.27 | 0.62 | -1.62 | 0.17 | -0.37 | 0.03 |
| Income before tax | -64.36 | -115.55 | -135.89 | -62.10 | -13.77 | -26.81 | -4.67 | -1.32 |
| Income tax expense | 2.06 | 0.71 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | |
| Net income | -66.42 | -115.55 | -135.89 | -62.09 | -13.83 | -26.81 | -4.67 | -1.32 |
Show Quarterly Income Statement
Income Statement - Tarsus Pharmaceuticals, Inc. (TARS)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Jun-18 | Mar-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 162.05 | 151.67 | 118.70 | 102.66 | 78.34 | 66.41 | 48.12 | 40.81 | 27.61 | 13.08 | 1.87 | 15.28 | 2.50 | 10.00 | 0.00 | 15.28 | 0.54 | 0.34 | 1.24 | 22.02 | 33.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Cost of revenue | 9.40 | 10.93 | 24.59 | 6.24 | 5.21 | 4.93 | 3.24 | 3.00 | 1.65 | 1.22 | 0.38 | 0.32 | 0.26 | 0.40 | 0.21 | 0.52 | 0.03 | -0.02 | 0.07 | 0.74 | 1.30 | 0.00 | 0.00 | 0.02 | |||||||||
| Gross profit | 152.66 | 140.74 | 94.10 | 96.42 | 73.12 | 61.48 | 44.88 | 37.81 | 25.96 | 11.86 | 1.49 | -0.32 | 2.25 | 9.60 | -0.21 | 14.76 | 0.51 | 0.36 | 1.18 | 21.28 | 32.13 | 0.00 | 0.00 | -0.02 | |||||||||
| Total operating expenses | 158.78 | 148.72 | 108.63 | 118.61 | 99.40 | 85.90 | 70.04 | 71.11 | 63.64 | 56.31 | 42.43 | 32.51 | 27.20 | 24.66 | 22.70 | 19.98 | 20.03 | 14.81 | 16.88 | 14.00 | 21.42 | 11.48 | 10.14 | 3.26 | 2.12 | 1.08 | 0.61 | -0.34 | -0.34 | ||||
| Operating income | -6.12 | -7.98 | -14.53 | -22.18 | -26.28 | -24.42 | -25.16 | -33.30 | -37.68 | -44.45 | -40.94 | -32.82 | -24.95 | -15.06 | -22.91 | -5.22 | -19.52 | -14.45 | -15.71 | 7.28 | 10.71 | -11.48 | -10.14 | -3.26 | -2.12 | -1.08 | -0.63 | -1.07 | -1.07 | -1.07 | -0.34 | -0.34 | -0.34 |
| Non-operating income (net) | -3.20 | 1.66 | 1.94 | 1.84 | 1.16 | 1.31 | 1.74 | 0.01 | 1.95 | 2.55 | 1.79 | 1.40 | 1.53 | 1.46 | 0.39 | -0.52 | -0.72 | -0.35 | -0.33 | -0.91 | -0.03 | 0.01 | 0.00 | 0.01 | 0.16 | -0.33 | -0.05 | -0.09 | -0.09 | -0.09 | 0.01 | 0.01 | 0.01 |
| Income before tax | -9.32 | -6.31 | -12.59 | -20.34 | -25.12 | -23.11 | -23.42 | -33.29 | -35.73 | -41.90 | -39.15 | -31.42 | -23.42 | -13.60 | -22.52 | -5.74 | -20.24 | -14.80 | -16.04 | 6.37 | 10.69 | -11.47 | -10.14 | -3.25 | -1.96 | -1.41 | -0.68 | -1.17 | -1.17 | -1.17 | -0.33 | -0.33 | -0.33 |
| Income tax expense | -2.35 | 2.06 | -0.27 | 30.40 | -1.79 | -27.08 | -1.53 | -0.52 | -0.01 | 0.52 | 0.00 | 0.05 | -0.34 | 0.03 | 0.31 | 0.00 | 0.00 | 0.33 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Net income | -6.97 | -8.37 | -12.59 | -20.34 | -25.12 | -23.11 | -23.42 | -33.29 | -35.73 | -41.90 | -39.15 | -31.42 | -23.42 | -13.60 | -22.51 | -5.74 | -20.24 | -14.85 | -15.70 | 6.30 | 10.29 | -11.47 | -10.14 | -3.25 | -1.96 | -1.41 | -0.68 | -1.17 | -1.17 | -1.17 | -0.33 | -0.33 | -0.33 |